MIF and cancer: Theoretically, immunotherapeutic vaccines have merit over chemical inhibitors or anti-MIF antibodies since the former can also lead to a cell-mediated immune response against MIF-producing cancer cells in addition to a humoral immune response against MIF capable of neutralizing MIF activity.